|
Valsartan and Hydrochlorothiazide
|
|
Diovan HCT
|
Valsartan and Hydrochlorothiazide Clinical Trials
- Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
ClinicalTrials.gov Identifier: NCT00439738 - Active, not recruiting
Hypertension
- Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
ClinicalTrials.gov Identifier: NCT00425997 - Active, not recruiting
Hypertension
- Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00500604 - Recruiting
Hypertension
- A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
ClinicalTrials.gov Identifier: NCT00386607 - Active, not recruiting
Hypertension
- Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
Hypertension
- Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00396656 - Active, not recruiting
Hypertension
- Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
ClinicalTrials.gov Identifier: NCT00170989 - Completed
Hypertension
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00277472 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00280540 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
ClinicalTrials.gov Identifier: NCT00400777 - Active, not recruiting
Hypertension
- A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg [Micardis HCT] Versus Valsartan 160 Mg + Hydrochlorothiazide 25 Mg [Diovan HCT] Taken Orally for Eight Weeks in Patien
ClinicalTrials.gov Identifier: NCT00168779 - Completed
Hypertension
- A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
ClinicalTrials.gov Identifier: NCT00219102 - Active, not recruiting
Hypertension; Diabetes
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
ClinicalTrials.gov Identifier: NCT00360178 - Completed
Hypertension
- Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00548067 - Recruiting
Hypertension
- Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
ClinicalTrials.gov Identifier: NCT00487123 - Recruiting
Hypertension
- A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00170937 - Active, not recruiting
Metabolic Syndrome; Hypertension; Pre-Hypertension
- Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
ClinicalTrials.gov Identifier: NCT00446563 - Active, not recruiting
Hypertension; Hypertrophy, Left Ventricular
- A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril
ClinicalTrials.gov Identifier: NCT00171119 - Active, not recruiting
Hypertension; Diabetic Nephropathy
- Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00387517 - Active, not recruiting
Hypertension
- Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease
ClinicalTrials.gov Identifier: NCT00190580 - Recruiting
Chronic Kidney Disease; Hypertension
- Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
ClinicalTrials.gov Identifier: NCT00171561 - Completed
Hypertension
- A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00241007 - Completed
Hypertension
- Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
ClinicalTrials.gov Identifier: NCT00273299 - Completed
Hypertension
- A Morbi-Mortality and Remodeling Study with Valsartan
ClinicalTrials.gov Identifier: NCT00133328 - Active, not recruiting
Hypertension; Ischemic Heart Disease; Congestive Heart Failure
- Valsartan in Cardiovascular Disease with Renal Dysfunction (The V-CARD) Study
ClinicalTrials.gov Identifier: NCT00140790 - Recruiting
Hypertension; Renal Dysfunction
- A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension.
ClinicalTrials.gov Identifier: NCT00153049 - Completed
Hypertension
- Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril
ClinicalTrials.gov Identifier: NCT00394394 - Completed
Hypertension
- A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison with Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients with Mild to Modera
ClinicalTrials.gov Identifier: NCT00133185 - Completed
Hypertension
- Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
ClinicalTrials.gov Identifier: NCT00282178 - Active, not recruiting
Hypertension; Obesity
- Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin
ClinicalTrials.gov Identifier: NCT00385931 - Completed
Hypertension; Hypercholesterolemia; Dyslipidemia
- Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone
ClinicalTrials.gov Identifier: NCT00170963 - Completed
Hypertension
- Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study)
ClinicalTrials.gov Identifier: NCT00149227 - Recruiting
Hypertension; Ischemic Heart Disease; Congestive Heart Failure; Stroke
- A Study to Describe Vascular and Renal Effects and Safety of Valsartan in Patients With High Blood Pressure
ClinicalTrials.gov Identifier: NCT00171353 - Active, not recruiting
Hypertension
- A Clinical Study to Evaluate the Long-Term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
ClinicalTrials.gov Identifier: NCT00171405 - Active, not recruiting
Hypertension
- Comparison of Valsartan with Amlodipine in Hypertensive Patients with Glucose Intolerance
ClinicalTrials.gov Identifier: NCT00129233 - Recruiting
Hypertension; Type 2 Diabetes Mellitus; Impaired Glucose Tolerance
- Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension
ClinicalTrials.gov Identifier: NCT00171054 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan and Amlodipine in Adults With Moderate, Inadequately Controlled Hypertension
ClinicalTrials.gov Identifier: NCT00523744 - Active, not recruiting
Hypertension
- Safety and Efficacy of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS
ClinicalTrials.gov Identifier: NCT00308425 - Active, not recruiting
De Novo Renal Transplantation
- Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
ClinicalTrials.gov Identifier: NCT00443612 - Recruiting
Hypertension
- Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
ClinicalTrials.gov Identifier: NCT00232882 - Recruiting
Hypertension
- Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
ClinicalTrials.gov Identifier: NCT00509470 - Recruiting
Essential Hypertension
- Effects of Blood Pressure Reduction on High Sensitivity C-Reactive Protein (hsCRP)
ClinicalTrials.gov Identifier: NCT00154271 - Completed
Hypertension
- GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
ClinicalTrials.gov Identifier: NCT00376272 - Active, not recruiting
Atrial Fibrillation
- Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)
ClinicalTrials.gov Identifier: NCT00446524 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan Versus Placebo on Exercise Tolerance in Patients With Heart Failure
ClinicalTrials.gov Identifier: NCT00171106 - Active, not recruiting
Diastolic Dysfunction, Symptomatic Heart Failure
- To Compare the Efficacy and Safety of TW vs Valsartan in the MN
ClinicalTrials.gov Identifier: NCT00518219 - Recruiting
Membranous Nephropathy
- To Compare the Efficacy and Safety of TW vs Valsartan in the DN
ClinicalTrials.gov Identifier: NCT00518362 - Recruiting
Diabetic Nephropathy
- Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00413049 - Active, not recruiting
Hypertension
- Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00413413 - Active, not recruiting
Hypertension
- Valsartan Optimal Therapy Against Elevated Home Blood Pressure Research（VOYAGER）Study
ClinicalTrials.gov Identifier: NCT00460213 - Recruiting
Hypertension
- A 10-12 Week Study to Evaluate the Safety and Efficacy of 320 mg Valsartan and 80 mg Simvastatin in Combination and as Monotherapies in Treating Hypertension and Hypercholesterolemia
ClinicalTrials.gov Identifier: NCT00171093 - Active, not recruiting
Hypertension; Hypercholesterolemia
- Open Label Extension Study to Evaluate the Long Term Use of Valsartan in 1-5 Year Old Hypertensive Children
ClinicalTrials.gov Identifier: NCT00457626 - Recruiting
Hypertension
- Safety and Efficacy of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00437645 - Active, not recruiting
Essential Hypertension
- The Vascular Effects of Carvedilol CR + Lisinopril Versus Lisinopril + Hydrochlorothiazide in Abdominally Obese Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00459056 - Recruiting
Abdominal Obesity; Hypertension
- Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy
ClinicalTrials.gov Identifier: NCT00351130 - Active, not recruiting
Hypertension
- A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
ClinicalTrials.gov Identifier: NCT00426348 - Recruiting
Glomerulonephritis, IGA
- Long Term Safety, Tolerability and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension
ClinicalTrials.gov Identifier: NCT00446511 - Recruiting
Hypertension
- A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure
ClinicalTrials.gov Identifier: NCT00294086 - Active, not recruiting
Chronic Heart Failure
- To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00550095 - Recruiting
Microalbuminuria; Proteinuria
- A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg
ClinicalTrials.gov Identifier: NCT00241137 - Completed
Hypertension
- Losartan vs. Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
ClinicalTrials.gov Identifier: NCT00388388 - Recruiting
Pre-Hypertension; Pre-Diabetes
- A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-Label, Blinded
ClinicalTrials.gov Identifier: NCT00240474 - Completed
Hypertension
- Telmisartan vs. valsartan missed dose
ClinicalTrials.gov Identifier: NCT00034840 - Completed
Hypertension
- To Compare the Blood Level of Marketed Japanese Valsartan Tablet Formulation vs Global Valsartan Tablet Formulation in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00415883 - Completed
Healthy
- Hydrochlorothiazide (+) Losartan Potassium Vs. Amlodipine Comparative Study
ClinicalTrials.gov Identifier: NCT00157963 - Completed
Essential Hypertension
- Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure
ClinicalTrials.gov Identifier: NCT00433836 - Recruiting
Hypertension
- Dose Response of Valsartan on Sitting Systolic Blood Pressure in 1-5 Year Old Children With High Blood Pressure
ClinicalTrials.gov Identifier: NCT00435162 - Recruiting
Hypertension
- Prevention of CHOP-Induced Chronic Cardiotoxicity
ClinicalTrials.gov Identifier: NCT00162955 - Recruiting
Non-Hodgkin''s Lymphoma
- Long-term Study of Starlix+Diovan to Delay Type II Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00097786 - Active, not recruiting
Diabetes Mellitus, Type 2
- Effect of Valsartan on Carotid Artery Disease
ClinicalTrials.gov Identifier: NCT00208767 - Recruiting
Carotid Artery Diseases; Atherosclerosis
- Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00425373 - Recruiting
Essential Hypertension
- Open-Label Trial of the Efficacy and Safety of Combination of Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg Tablets in Patients With Hypertension.
ClinicalTrials.gov Identifier: NCT00267943 - Completed
Hypertension
- Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome
ClinicalTrials.gov Identifier: NCT00409578 - Recruiting
Post Acute Coronary Syndrome; Myocardial Ischemia
- The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction
ClinicalTrials.gov Identifier: NCT00523549 - Recruiting
Hypertension; Diastolic Dysfunction
- Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00139698 - Completed
Essential Hypertension
- Valsartan in Elderly Isolated Systolic Hypertension (VALISH) Study
ClinicalTrials.gov Identifier: NCT00151229 - Active, not recruiting
Elderly; Isolated Systolic Hypertension
- Effectiveness of Losartan 50 mg/HCTZ 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Hypertension Not Controlled on Monotherapy
ClinicalTrials.gov Identifier: NCT00546754 - Recruiting
Hypertension
- Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients
ClinicalTrials.gov Identifier: NCT00409487 - Not yet recruiting
Hypertension,; Obstructive Sleep Apnea
- A Prospective, Randomised, Double-Blind, Double-Dummy, Forced-Titration, Multicentre, Parallel Group, One Year Treatment Trial to Investigate the Efficacy of Telmisartan 80 Mg Versus Valsartan 160 Mg in Hypertensive Type 2 Diabetic Patients with Overt Nep
ClinicalTrials.gov Identifier: NCT00153023 - Completed
Diabetic Nephropathies; Hypertension
- Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
ClinicalTrials.gov Identifier: NCT00430508 - Not yet recruiting
Essential Hypertension
- Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
ClinicalTrials.gov Identifier: NCT00430950 - Not yet recruiting
Essential Hypertension
- Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
ClinicalTrials.gov Identifier: NCT00263393 - Recruiting
* Myocardial Infarction; Angina Pectoris; Cerebrovascular Accidents; Diabetes Mellitus
- An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hy
ClinicalTrials.gov Identifier: NCT00449111 - Terminated
Hypertension
- Antiproteinuric Effect of Valsartan and Lisinopril
ClinicalTrials.gov Identifier: NCT00171574 - Completed
Hypertension; Diabetic Nephropathy
- VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria
ClinicalTrials.gov Identifier: NCT00171067 - Completed
Hypertension
- Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One Dose
ClinicalTrials.gov Identifier: NCT00302705 - Completed
Hypertension
- A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00392262 - Completed
Hypertension
- Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00409643 - Completed
Hypertension
- Avoiding Cardiovascular Events through Combination therapy in patients with Systolic Hypertension ACCOMPLISH
ClinicalTrials.gov Identifier: NCT00097864 - No longer recruiting
Heart Disease
- Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With Diabetes
ClinicalTrials.gov Identifier: NCT00241124 - Completed
Hypertension
- VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil
ClinicalTrials.gov Identifier: NCT00171015 - Completed
Hypertension
- A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on Monotherapy
ClinicalTrials.gov Identifier: NCT00327145 - Completed
Hypertension
- VALENCE: Valsartan Versus Atenolol on Exercise Capacity in Hypertensive Overweight Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00171132 - Completed
Hypertension
- Study to Compare the Effect of Valsartan vs Atenolol on Pro-Thrombotic State in Hypertensive Patients.
ClinicalTrials.gov Identifier: NCT00171756 - Completed
Hypertension
- VALIDATE Valsartan and Supportive Measures - Impact on Drug Adherence of Treated Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00394823 - Completed
Hypertension
- Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
ClinicalTrials.gov Identifier: NCT00355589 - Completed
Hypertension; Blood Pressure, High
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00367094 - Completed
Hypertension
- Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00219037 - Completed
Hypertension
- Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
ClinicalTrials.gov Identifier: NCT00219024 - Completed
Hypertension
- Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension
ClinicalTrials.gov Identifier: NCT00171535 - Completed
Hypertension
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
